Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts

NCT00058812 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Epstein-Barr Virus Infections

Interventions

BIOLOGICAL: EBV specific T cells

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]